[A chimeric cytokine to help autoimmune diseases].
Rafei
Moutih
M
Université de Montréal, Montréal, Québec, H3C 3J7 Canada.
Galipeau
Jacques
J
D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000637:transplantation; D016207:Cytokines / Q000494:pharmacology / Q000627:therapeutic use; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D016219:Immunotherapy, Adoptive; D051379:Mice; D009103:Multiple Sclerosis / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy / Q000628:therapy; D053647:Receptors, Interleukin-15 / Q000187:drug effects; D011993:Recombinant Fusion Proteins / Q000494:pharmacology / Q000627:therapeutic use; D050796:STAT3 Transcription Factor / Q000502:physiology; D023041:Xenograft Model Antitumor Assays
D016207:Cytokines; C549681:GIFT12 protein; C518130:GIFT15 protein; D053647:Receptors, Interleukin-15; D011993:Recombinant Fusion Proteins; D050796:STAT3 Transcription Factor